Search hospitals > Oregon > Portland
Providence Portland Medical Center
Claim this profilePortland, Oregon 97213
Global Leader in Skin Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Stomach Cancer
578 reported clinical trials
37 medical researchers
Summary
Providence Portland Medical Center is a medical facility located in Portland, Oregon. This center is recognized for care of Skin Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Stomach Cancer and other specialties. Providence Portland Medical Center is involved with conducting 578 clinical trials across 583 conditions. There are 37 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Rachel Sanborn, MD, and Nitya Alluri.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Alison K. ConlinProvidence Portland Medical Center6 years of reported clinical research
Expert in Skin Cancer
Expert in Breast Cancer
107 reported clinical trials
183 drugs studied
Charles W. DrescherProvidence Portland Medical Center8 years of reported clinical research
Expert in Skin Cancer
Studies Uterine Tumors
53 reported clinical trials
99 drugs studied
Rachel Sanborn, MDProvidence Portland Medical Center5 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
43 reported clinical trials
68 drugs studied
Nitya AlluriProvidence Portland Medical Center1 year of reported clinical research
Expert in Skin Cancer
Studies Relapse
28 reported clinical trials
79 drugs studied
Clinical Trials running at Providence Portland Medical Center
Breast Cancer
Lung Cancer
Skin Cancer
Prostate Cancer
Breast cancer
Non-Small Cell Lung Cancer
Pancreatic Cancer
Stomach Cancer
Multiple Myeloma
Ovarian Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Sacituzumab Tirumotecan + Pembrolizumab
for Breast Cancer
The purpose of this study is to compare sacituzumab tirumotecan as a single agent, and in combination with pembrolizumab, versus Treatment of Physician's Choice (TPC) in participants with hormone receptor positive/human epidermal growth factor receptor-2 negative (HR+/HER2-) unresectable locally advanced, or metastatic, breast cancer. The primary hypotheses are that sacituzumab tirumotecan as a single agent and sacituzumab tirumotecan plus pembrolizumab are superior to TPC with respect to progression-free survival (PFS) per Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST 1.1) by blinded independent central review (BICR) in all participants.
Recruiting2 awards Phase 33 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Providence Portland Medical Center?
Providence Portland Medical Center is a medical facility located in Portland, Oregon. This center is recognized for care of Skin Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Stomach Cancer and other specialties. Providence Portland Medical Center is involved with conducting 578 clinical trials across 583 conditions. There are 37 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Rachel Sanborn, MD, and Nitya Alluri.
Where is Providence Portland Medical Center located?
**Providence Portland Medical Center**
- **Address:** 4805 NE Glisan St, Portland, OR 97213
- **Accessibility:** Easily accessible via public transit, including bus and light rail options.
- **Specialties:** Renowned for excellence in cancer, heart, orthopedics, women's health, rehabilitation services, and behavioral health.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Providence Portland Medical Center:
- Contact financial counselors at **855-229-6466**, available Monday – Friday, 7 a.m. to 5:30 p.m. PT.
- For billing inquiries related to Providence Hospitals & Clinics, call **866-747-2455** (toll-free) or **503-574-5791** (local - Portland metro area).
- For billing inquiries related to Providence Health Plan, call **800-878-4445** (toll-free) or **503-574-5791** (local - Portland metro area).
What insurance does Providence Portland Medical Center accept?
Providence Portland Medical Center accepts a wide range of health plans, including Aetna, Blue Cross Blue Shield, Cigna, Coventry, First Health, Humana, MultiPlan, Private Healthcare Systems (PHCS), TRICARE for Life, United Healthcare, and more. The hospital also accepts various Medicare and Medicaid plans, alongside commercial/indemnity insurance plans. For the most accurate information regarding coverage, please check directly with your insurance provider and the hospital.
What awards or recognition has Providence Portland Medical Center received?
Providence Portland Medical Center, located in Portland, Oregon, has been awarded a Health Care Innovation Award of $17,337,093 for transforming the delivery system of Oregon's largest Medicaid Coordinated Care Organization (CCO). This initiative focuses on enhancing care coordination, quality, and outcomes for high-cost, high-acuity Medicaid patients while aiming to reduce overall health care costs. The hospital is renowned for its excellence in patient care and research, particularly in cancer, heart, orthopedics, women's health, rehabilitation services, and behavioral health, and holds the prestigious Magnet® designation for nursing excellence.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.